Honorary Professor

Kum Kum Khanna

Email: 

Availability

Honorary Professor Kum Kum Khanna is:
Available for supervision

Fields of research

Biological Sciences Oncology and carcinogenesis

Search Professor Kum Kum Khanna’s works on UQ eSpace

201 works between 1995 and 2025
All (201) Journal Article (188) Other Outputs (1) Conference Publication (12)

201 - 201 of 201 works

1995

Journal Article

Nature of G1/s cell-cycle checkpoint defect in ataxia-telangiectasia

Khanna, KK, Beamish, H, Yan, J, Hobson, K, Williams, R, Dunn, I and Lavin, MF (1995). Nature of G1/s cell-cycle checkpoint defect in ataxia-telangiectasia. Oncogene, 11 (4), 609-618.

Nature of G1/s cell-cycle checkpoint defect in ataxia-telangiectasia

Current funding

  • 2024 - 2026
    Targeting the redox niche in triple-negative breast cancer to treat brain metastases
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2024 - 2027
    Targeting metstatic breast cancer by oligonucleotide therapeutics with the FDA lipid nanoparticles (LNP) delivery system.
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant

Past funding

  • 2024
    Exploitation of immunogenicity of Cep 55 to enhance efficacy of therapy for triple-negative breast cancer
    National Breast Cancer Foundation Investigator Initiated Research Scheme
    Open grant
  • 2022 - 2025
    Targeting CEP55 in Triple-Negative Breast Cancer (US DoD CDMRP grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant

Availability

Honorary Professor Kum Kum Khanna is:
Available for supervision

Looking for a supervisor? Read our advice on how to choose a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Understanding novel regulators of mitosis and their implication in cancer

    Principal Advisor

  • Doctor Philosophy

    Functional validation of therapeutic targets for basal breast cancer

    Principal Advisor

  • Doctor Philosophy

    Validation of biomarkers and therapeutic targets to predict therapy response and sensitise high-grade serous ovarian cancer (HGSC) to chemotherapy.

    Principal Advisor

  • Doctor Philosophy

    Optimising systemic therapies of metastatic and recurrent triple-negative breast cancer using next generation 3D models

    Principal Advisor

  • Doctor Philosophy

    Designing Therapeutic Strategies Targeting KRAS

    Associate Advisor

  • Doctor Philosophy

    Investigating the diagnostic and functional significance of specific epigenomic features in triple-negative breast cancer (TNBC)

    Associate Advisor

    Other advisors: Dr Jodi Saunus

  • Doctor Philosophy

    Breaking barriers: unlocking the potential of cytomegalovirus-specific T cells in allogeneic CAR T cell therapies

    Associate Advisor

Completed supervision

Enquiries

For media enquiries about Honorary Professor Kum Kum Khanna's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au